CBME TIME TABLE – II MBBS BLOCK 1: March to June-2021

CBME TIME TABLE – II MBBS BLOCK 1: March to June-2021

SRI ADICHUNCHANAGIRI SHIKSHANA TRUST (R.) BGS GLOBAL INSTITUTE OF MEDICAL SCIENCES (Affiliated to Rajiv Gandhi University of Health Sciences, Bangalore) No. 67, BGS Health & Education City, Uttarahalli Road, Kengeri, Bangalore- 560060, Karnataka CBME TIME TABLE – II MBBS BLOCK 1: March TO June-2021 WEEK 1 DAY 8-11 11.30-12.30 12.30-1.30 2.00-4.00 4.00-5.00 Monday Postings L1 –PH: 1.1 OBG-LL1: OG 1.1: Integration: PH-A: PH: 1.1 MIC SDL 1 PSM: Birth rate, maternal 08/03/21 Batch A - Principles of mortality rate and morbidity Source of drug , drug information , Integration with Physiology and Gen Med pharmacology & drug compendia ,essential medicine, Pathology pharmacotherapeutics Formative Assessment: counterfeit drug , orphan drug. Batch B - Written/ Viva Assessment: Written/ viva Gen Sur Formative Assessment: MI 1.7.2 immune system Written/ Viva Batch C - Assessment: Written/ OBG Pharmacology –PH: 1.2: Therapeutic drug Monitoring & Clinical Trials Viva/MCQs Assessment: Short Notes Error! Not a valid embedded object. CM - B CM 7.2 - SGD-1: Cold chain system and its uses Assessment: Skill demo CM 7.3 - SGD-2: Integration Biochemistry Immunizing agents, national immunization schedule and vaccination strategies including vaccine development and implementation Assessment: MCQ/Viva Tuesday Postings L2 –PH: 1.3 & 1.11 FM: L1: SGD -1: FM- A: SGD-1 09/03/21 Batch A - Routes of Drug FM 1.1: Basics of Forensic PA 1.1 - Describe the role of a Gen Med administration medicine, Definition of FMT, pathologist in diagnosis and and its Sub Specialities management of disease Batch B - Formative Assessment: FM 2.8: Post Mortem Changes - ASSESSMENT: (written,viva-voce) Gen Sur Written/ Viva FM 1.2: History and Immediate & Early changes. Development of Forensic Batch C - medicine FM 2.10: Estimation of Time Since OBG Death ( TSD). Assessment: NIL Assessment: Written, viva voce Wednesda Postings MIC-L 1 PA Lecture -1: Practical-1 1 y Batch A - PA 1.2: Enumerate PA-A; PA 2.5-DOAP Gen Med common definitions and a Integration Community term used in pathology ASSESSMENT: SKILL 10/03/21 Batch B - Medicine ASSESSMENT Gen Sur PA 1.3: Describe the history and evolution of Batch C - pathology OBG MI 1.1.1 ASSESSMENT: (written,viva-voce) MIC-B Practical 1 Introduction to infectious diseases and History Microscopy - Types of microscopes, principle and application of each Formative Assessment: Written/ Viva voce Simple stain exercise and hanging drop demonstration Skill Assessment Thursday Maha Shivarathri 2 11/03/21 Friday Postings MIC-L 2 PA Lecture -2: PH-B: PH: 1.1 MIC Tutorial 1 12/03/21 Batch A - L3-PA- 2.1: Demonstrate Source of drug, drug information, Gen Med knowledge of the causes, drug compendia , essential medicine, MI 1.1.2 Mechanisms, type and counterfiet drug , orphan drug. Batch B - effects of cells injury and Gen Sur Pharmacology –PH: 1.2: Therapeutic their clinical significance drug Monitoring & Clinical Trials MI Batch C - Morphology of PA-2.2: Describe the Assessment:Written/ Viva 1.1.2 OBG Bacteria etiology of cell injury. Physiology of Bacteria Distinguish between 3 reversible - irreversible Assessment: Written/ injury: mechanisms; Viva/MCQs Formative Assessment: CM-A morphology of cell injury Written/ Viva voce ASSESSMENT: CM 7.2 - SGD-1: Cold chain system (written,viva-voce) and its uses Assessment: Skill demo CM 7.3 - SGD-2: Integration Biochemistry Immunizing agents, national immunization schedule and vaccination strategies including vaccine development and implementation Assessment: MCQ/Viva Saturday CLINICAL G.MED-L1: Obesity-I: SUR-L1: SU1.1: Integration: TRAININ IM 14.1 & 14.2: Pathology: Concepts of FM - B SGD: 1 Sports - Badminton 13/03/21 G & Definition, causes of homeostasis, metabolic SKILLS obesity (modifiable & changes in injury and non-modifiable) & mediators FM 2.8: Post Mortem Changes - concept of BMI Immediate & Early changes. Formative Assessment: Formative Assessment: Written/ Viva FM 2.10: Estimation of Time Since Written/ Viva Death ( TSD). 4 Assessment: Written, viva voce WEEK 2 DAY 8-11 11.30-12.30 12.30-1.30 2.00-4.00 4.00-5.00 Monday Postings L3–PH: 1.4 OBG-L2: OG 1.2: Integration PH-A:PH 1.3 & 1.9 PSM & Pediatrics: Perinatal MIC SDL 2 15/03/21 Batch A - Gen Pharmacokinetics- mortality and morbidity & Drug formulations & drug Med I - Drug delivery system calculation & interpretation Absorption & MI 1.7.3 Batch B - Gen of demographic indices •Drug dosage forms Distribution Sur Antigen Formative Assessment: SkillAssessment Formative Written/ Viva Batch C - OBG Assessment: Assessment: CM-B Written/ Written/ Viva Viva/MCQs CM 7.2 - SDG 3 : Disinfection and disinfecting agentsAssessment: written/viva CM 7.4 - SGD 4: Integration General Medicine Morbidity indicators - Calculation and 5 interpretation. Assessment: written/ skill assessment Tuesday Postings L4: PH: 1.4 SGD-2 FM-L 2: FM-A: SGD 2: 16/03/21 Batch A - Gen Pharmacokinetics- PA - 2.6: Describe Med II FM 2.1: Death and its FM 2.9: Late changes after and discuss cellular types. death. adaptation: atrophy, Batch B - Gen Drug Metabolism hypertrophy, Sur & Excretion FM 2.2: Natural and FM 2.18: CSI ( Crime Scene hyperplasia, unnatural deaths Investigation) Batch C - OBG Formative metaplasia, dysplasia Assessment: FM 2.3: Issues related to Assessment: Written, viva ASSESSMENT: Written/ Viva sudden natural deaths voce (written,viva-voce) Assessment: Written, viva voce Wednesday Postings MIC-L3 PA-Lecture 3: PA 2.4: Practical - 2: FM - SDL 1 Describe and discuss cell 17/03/21 Batch A - Gen death- Apoptosis and PA-A; PA-2.8, DOAP Assessment: Med autolysis. Written MI ASSESSMENT: SKILL Batch B - Gen ASSESSMENT: ASSESSMENT FM 2.4: Salient features and Ethical 6 Sur 1.1.3 (written,viva-voce) issues of Human organ transplantation Batch C - OBG (amendment) act 2011 Introduction to virology MIC-B Practical 2 Formative MI 1.1.2.3 Culture media and Assessment: methods (including anaerobic) Written/ Viva voce Assessment: Written, viva voce Thursday Postings CM - L1 - 7.1: PH: SGD 1: Evidence-based Practical - 1: PH: SDL 1: Medicine & TDM 18/03/21 Batch A - Gen Integration PA-B,PA- 2.5. a. Membrane transport Med General Medicine & barriers DOAP Batch B - Gen Epidemiology - b. Body compartment & Sur Define, Principles, ASSESSMENT: SKILL fluid distribution concepts and uses ASSESSMENT Batch C - OBG Assessment: 7 Short Essay / Viva MIC-A Practical 1 Microscopy - Types of microscopes, principles and applications of each Simple stain exercise and hanging drop demonstration Skill Assessment Friday Postings MIC-L 4 Lecture -4: PH-B: Practical 2: PH 1.3 & 1.9 MIC Tutorial 2 19/03/21 Batch A - Gen PA 2.7: Describe and Enumerate & identify drug Med discuss the mechanisms of formulations & drug delivery MI 1.1.3 MI 1.1.4 cellular aging and system Batch B - Gen Introduction to apoptosis. Sur •Drug dosage forms 8 Batch C - OBG Introduction to PA 2.3: Intracellular SkillAssessment virology-II mycology accumulation of fats, proteins, carbohydrates, Assessment: Written/ pigments Viva/MCQs Formative ASSESSMENT: Assessment: CM-A : Written/ Viva (written,viva-voce) voce CM 7.2 - SDG 3 : Disinfection and disinfecting agents Assessment: written/viva CM 7.4 - SGD 4: Integration General Medicine Morbidity indicators - Calculation and interpretation. Assessment: written/ skill assessment Saturday CLINICAL G.MED-L2: SUR-L2: SU 1.2: Metabolic TRAINING & Obesity 2: IM 14.3 stress response to surgery FM-B: SGD 2: FM 2.9: Late Sports - Athletics 20/03/21 SKILLS & 14.4: and trauma: the ‘ebb and changes after death. Monogenic forms, flow’ model FM 2 host-environment .18: CSI ( Crime Scene interactions Formative Assessment: Investigation) Written/ Viva Formative Assessment: Written, viva Assessment: voce 9 Written/ Viva WEEK 3 DAY 8-11 11.30-12.30 12.30-1.30 2.00-4.00 4.00-5.00 Monday Postings L5 –PH: 1.5 OBG-L3: OG 2.1: PH-A: Practical 3: PH 1.3 Integration – MIC SDL 3 22/03/21 Batch A - Gen Pharmacodynamics- Anatomy: Drug formulations & drug delivery Integration with Med I: General principles Anatomy of the system of drug action Pathology Batch B - Gen female FA: SkillAssessment reproductive Sur Formative Assessment: tract Batch C - OBG Written/ Viva Formative CM-B Assessment: Immunoglobulins Written/ Viva CM 7.4 - SGD 5 : Assessment: Written/ Viva/MCQs Integration General Medicine Mortality indicators - calculation and interpretation. Assessment: written/ skill assessment CM 7.5 - SGD 6 : Select the appropriate study designs for a given research 10 question Assessment: written/ skill assessment Tuesday Postings L6–PH: 1.5 SGD-3 FM L3: FM 2.5: FM-A: 23/03/21 Batch A - Gen Pharmacodynamics- Moment and PA-3.1 - Describe the Med II: Mechanism of Modes of death, SGD 3: FM 14.9: Skeletal remains pathogenesis and drug action & FM 2.6: examination and reporting in a simulated/ pathology of Batch B - Gen supervised environment. factors modifying & Presumption of amyloidosis Sur clinical implications death and survivorship FM 2.16: Examination of mutilated 3.2 - Identify and Batch C - OBG bodies or fragments, charred bones. Formative describe amyloidosis Assessment: FM 2.7: in a pathology Suspended Assessment: Written, viva voce, Written/ Viva specimen animation OSPE, Practical book, Log book, viva voce ASSESSMENT: Assessment: (written,viva-voce) Written 11 Wednesday Postings MIC-L 5 Lecture -5: Practical - 3: 24/03/21 Batch A - Gen PA-L PA-A, PA 4.4- acute inflammation Med MI 1.1.5 PA 4.1: Define DOAP Batch B - Gen and describe the Sur general features ASSESSMENT: SKILL ASSESSMENT Introduction to of acute

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    249 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us